DOCSLIB.ORG

Vascular Procr+ Stem Cells: Finding New Branches While Looking for the Roots Cell Research (2016) 26:1071-1072

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Vascular Procr+ Stem Cells: Finding New Branches While Looking for the Roots Cell Research (2016) 26:1071-1072 Cell Research (2016) 26:1071-1072. © 2016 IBCB, SIBS, CAS All rights reserved 1001-0602/16 $ 32.00 RESEARCH HIGHLIGHT www.nature.com/cr Vascular Procr+ stem cells: Finding new branches while looking for the roots Cell Research (2016) 26:1071-1072. doi:10.1038/cr.2016.91; published online 2 August 2016 Generation and growth of the cells are the major source of mature Procr+ endothelial cells in vivo, Yu et blood vasculature network is a highly endothelial cells for vascular renewal al. elegantly carried out lineage trac- synchronized process, requiring coor- and repair, over bone marrow-derived ing experiments, revealing that Procr+ dinated efforts of endothelial cells and endothelial precursors [1]. The report endothelial cells not only significantly pericytes to maintain blood vessel in- by Yu et al. [2] provides strong evidence contribute to adult neovascularization, tegrity and regeneration. In a recent to support this concept and identifies but unexpectedly, are bipotent stem cells paper published in Cell Research, Yu protein C receptor-expressing (Procr, which can also give rise to pericytes in et al. identified and characterized also known as endothelial protein C normal development and homeostasis. bipotent Procr-expressing vascular receptor — EPCR) endothelial stem To the best of our knowledge and under- endothelial stem cells, which give rise cells as the apex of the bipotent lineage standing, this is the first documentation to both endothelial cells and pericytes. tree for both endothelial cells and peri- of an adult bipotent common vascular The vasculature is a complex trans- cytes, providing new understanding on progenitor that gives rise to both endo- port system, composed of a remarkable the root of adult neovascularization in thelial and periendothelial cells. These network of arteries, veins and connect- homeostasis and injury repair. results are in line with previous obser- ing capillaries of the blood system that To identify vascular endothelial stem vations revealing a common bipotent supply every organ with oxygen and cells (VESCs), Yu and colleagues took embryonic vascular progenitor cell that nutrients. Blood vessels also regulate advantage of the mammary gland which differentiates into both endothelial and organ development, regeneration and develops mostly in the postnatal stage. smooth muscle cells [3]. stem cell behavior. Endothelial stem The authors demonstrate that Procr- Procr has been identified as a stem cells are highly plastic and can rapidly expressing endothelial stem cells exhibit cell marker also in various other tis- switch from long-term quiescence to ac- robust in vitro clonogenic potential and sues including long-term repopulating tive angiogenic growth upon metabolic that their stemness capacities can be hematopoietic stem cells (LT-HSCs) in and stress stimulations. Vascular growth retained in culture. Importantly, when the fetal liver during embryo develop- and remodeling are vital for successful transplanted into an empty fat pad of ment [4] and adult bone marrow [5, 6], organ growth and play a major role in pubertal recipients, Procr-expressing and more recently in mammary stem tissue repair. However, this dynamic endothelial stem cells could functionally cells [7]. Procr has clear endothelial property also holds dark sides as vas- incorporate into an existing vessel and characteristics, and its ligation with cular sprouting provides survival and form new vessels in the mammary fat the serine protease, activated protein C growth cues to allow tumor progression pads, demonstrating robust regenerative (aPC), induces classic PAR1-mediated and metastasis spreading. Identifying capacity of Procr+ VESCs. The authors anticoagulation with anti-apoptotic and the root origin of the vascular segments extend their observations and show that anti-inflammatory activities, as well as could potentially make it possible to aid Procr is a common marker for VESCs promotes endothelial barrier protection in the development of therapies to pro- in the vasculature of other adult tissues, and stabilization [8]. Current evidence mote vascular repair or to prevent blood including the skin and retina. Targeted reveals that the aPC/EPCR pathway vessel growth within tumors. During ablation of Procr-expressing endothelial plays an important role in both fetal the last decade, much effort has been cells revealed the functional importance hematopoietic stem cell survival [4] devoted toward isolating and character- of Procr+ VESCs for blood vessel devel- and adult LT-HSC retention in the bone izing the adult stem cells that give rise opment and regeneration during normal marrow and protection from myelo- to the vascular endothelium. A growing retinal development and in vascular res- toxic insult [9]. Protection from DNA body of evidence indicates that tissue- toration upon hind limb ischemic injury. damaging agents via aPC/EPCR/PAR1 resident endothelial stem and progenitor To further verify the clonogenicity of signaling limits nitric oxide generation www.cell-research.com | Cell Research | SPRINGER NATURE 1072 and Cdc42 activity, leading to enhanced mary stem cell population [7], but is also pericyte cell population? Whether VLA4-mediated adhesion and stem cell highly expressed by a cancer stem cell- resident Procr+ stem cell pool becomes retention to ensure preservation of the like populations in aggressive human exhausted in disease states, aging and bone marrow stem cell pool [9]. Pres- breast cancer cells [12]. Since cancer- upon vascular injury remains to be ervation of Procr expression among dif- initiating cells are the lineage tree origin determined. Differences in the gene ferent stem cell types strongly implies for chemotherapy resistance and disease expression profile of Procr+ VESCs that Procr provides common stem cell relapse, a better understanding of how a versus hematopoietic and mammary signals, which may preserve the ‘stem- single Procr+ stem cell remains dormant stem cells may contribute to our global ness’ phenotype (Figure 1). within its niches and how it is protected understanding on ‘stemness’ identity The cancer stem cell paradigm refers will broaden our knowledge of how to and to further determination of their to the ability of cancer cell subpopula- eliminate the hiding cancer stem cell. phenotypic properties. The study by Yu tion to initiate tumorigenesis by under- In light of these important observa- et al. may also have therapeutic impli- going extensive self-renewal and dif- tions, the study by Yu et al. [2] opens cations as neovascularization holds the ferentiation [10]. It becomes clear that up new horizons, but raises questions key to wound healing, and angiogenesis the high frequency of relapse predicts at the same time. Based on the bipotent is a target for antitumor treatments. For that cancer stem cells are resistant to potential of Procr+ endothelial cells, example, does induction of Procr by standard therapy [11], therefore making what is the mechanism that triggers Wnt signaling [7] or activation by its strong claim that targeting the stem cell the endothelial regeneration process ligand aPC initiate vascular growth? population will likely lead to improved of Procr-expressing stem cells? What On the other hand, could targeting Procr patient outcomes. Procr was identified are the signals that enable coordinate by neutralizing antibodies be beneficial as a marker not only for healthy mam- differentiation to both endothelial and in fighting cancer? Finding an answer to those potentially clinically-relevant questions might yield an exciting find- ing and a rewarding journey. Shiri Gur-Cohen1, Tsvee Lapidot1 1Weizmann Institute of Science, Immunology Department, Rehovot, Israel Correspondence: Tsvee Lapidot E-mail: [email protected] References 1 Rinkevich Y, Lindau P, Ueno H, et al. Na- ture 2011; 476:409-413. 2 Yu QC, Song W, Wang D, et al. Cell Res 2016; 26:1079-1098. 3 Yamashita J, Itoh H, Hirashima M, et al. Na- ture 2000; 408:92-96. 4 Iwasaki H, Arai F, Kubota Y, et al. Blood 2010; 116:544-553. 5 Kent DG, Copley MR, Benz C, et al. Blood 2009; 113:6342-6350. 6 Balazs AB, Fabian AJ, Esmon CT, et al. Blood 2006; 107:2317-2321. 7 Wang D, Cai C, Dong X, et al. Nature 2015; 517:81-84. 8 Esmon CT. Semin Immunopathol 2012; 34:127-132. Figure 1 Procr is widely expressed by stem cells in various tissues. (A) Procr is 9 Gur-Cohen S, Itkin T, Chakrabarty S, et al. expressed by vascular endothelial stem cells (VESCs). Procr+ VESCs are bipotent, Nat Med 2015; 21:1307-1317. giving rise to endothelial cells and pericytes. (B) Procr is expressed by mammary 10 Lapidot T, Sirard C, Vormoor J, et al. Nature stem cells (MaSCs), and can be differentiated into all lineages of the mammary epi- 1994; 367:645-648. thelium including basal and luminal cells. (C) Procr (EPCR) is highly expressed by 11 Ding L, Ley TJ, Larson DE, et al. Nature bone marrow hematopoietic stem cells (HSCs) located in a thrombomodulin- and 2012; 481:506-510. aPC-enriched arterial microenvironment. EPCR signaling, manifested by aPC liga- 12 Schaffner F, Yokota N, Carneiro-Lobo T, et tion, promotes stem cell retention in the bone marrow and protection from cytotoxic al. PLoS One 2013; 8:e61071. damage. SPRINGER NATURE | Cell Research | Vol 26 No 10 | October 2016.
Load more

Recommended publications
  • Stem Cells and Cancer
    Stem Cells and Cancer Cancer Education Project Stem Cells and Cancer Overview: This series of activities is designed to introduce students to the theory that some cancers arise from cancer stem cells. This theory provides a possible explanation for why cancers reoccur after cancer treatment. It also provides insights that may lead to new types of chemotherapy drugs. • Part 1: Stem Cells and Cancer PowerPoint (40 minutes) Students view a PowerPoint presentation that introduces stem cell biology and shows ways that cancer stem cell research might lead to more effective cancer therapy treatments. Students answer questions as they view the PowerPoint. Then they create a cartoon strip to illustrate their understanding of cancer stem cells. • Part 2: The Bad Seed: Rare stem cells appear to drive cancers (20 minutes) Students read a brief article that introduces stem cell biology and explains how cancer stem cell research might lead to more effective cancer therapy treatments. Students answer questions based on this article. This activity may be done in class or for homework. • Part 3: Plant Derivative Attacks the Roots of Leukemia (20 minutes) Students read a brief article on the development of a potential chemotherapy agent that specifically targets cancer stem cells. Students answer questions based on this article. This activity may be done in class or for homework. • Part 4: Clinical Trials: Parthocet (40 minutes) Students answer questions about the design of a large-scale, randomized, double-blind clinical trial to determine if Parthocet (a fictitious chemotherapy drug) is safe and effective. Life Sciences Learning Center – Cancer Education Project 1 Copyright © 2007, University of Rochester May be copied for classroom use Stem Cells and Cancer Teacher Instructions - Part 1 Stem Cells and Cancer PowerPoint Presentation Students view a PowerPoint presentation that introduces stem cell biology and shows ways that cancer stem cell research might lead to more effective cancer therapy treatments.
    [Show full text]
  • Cancer Stem Cells and Nucleolin As Drivers of Carcinogenesis
    pharmaceuticals Review Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis Laura Sofia Carvalho 1,Nélio Gonçalves 1 , Nuno André Fonseca 1,2 and João Nuno Moreira 1,3,* 1 CNC—Center for Neurosciences and Cell Biology, Center for Innovative Biomedicine and Biotechnology (CIBB), Faculty of Medicine (Polo 1), University of Coimbra, Rua Larga, 3004-504 Coimbra, Portugal; laurasofi[email protected] (L.S.C.); [email protected] (N.G.); [email protected] (N.A.F.) 2 TREAT U, SA—Parque Industrial de Taveiro, Lote 44, 3045-508 Coimbra, Portugal 3 UC—University of Coimbra, CIBB, Faculty of Pharmacy (FFUC), Pólo das Ciências da Saúde, Azinhaga de Santa Comba, 3000-548 Coimbra, Portugal * Correspondence: [email protected]; Tel.: +351-239-820-190 Abstract: Cancer, one of the most mortal diseases worldwide, is characterized by the gain of specific features and cellular heterogeneity. Clonal evolution is an established theory to explain heterogeneity, but the discovery of cancer stem cells expanded the concept to include the hierarchical growth and plasticity of cancer cells. The activation of epithelial-to-mesenchymal transition and its molecular players are widely correlated with the presence of cancer stem cells in tumors. Moreover, the acquisition of certain oncological features may be partially attributed to alterations in the levels, location or function of nucleolin, a multifunctional protein involved in several cellular processes. This review aims at integrating the established hallmarks of cancer with the plasticity of cancer cells as an emerging hallmark; responsible for tumor heterogeneity; therapy resistance and relapse. The discussion will contextualize the involvement of nucleolin in the establishment of cancer hallmarks and its application as a marker protein for targeted anticancer therapies Keywords: tumor heterogeneity; drug resistance; cancer stem cells; nucleolin; targeted therapies; epithelial-to-mesenchymal transition Citation: Carvalho, L.S.; Gonçalves, N.; Fonseca, N.A.; Moreira, J.N.
    [Show full text]
  • Cancer from the Perspective of Stem Cells and Misappropriated Tissue Regeneration Mechanisms
    Leukemia (2018) 32:2519–2526 https://doi.org/10.1038/s41375-018-0294-7 REVIEW ARTICLE Corrected: Correction Stem cell biology Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms 1,2 1 1 1,2 1 Mariusz Z. Ratajczak ● Kamila Bujko ● Aaron Mack ● Magda Kucia ● Janina Ratajczak Received: 8 September 2018 / Accepted: 17 September 2018 / Published online: 30 October 2018 © The Author(s) 2018. This article is published with open access Abstract Tumorigenesis can be considered as pathologically misappropriated tissue regeneration. In this review we will address some unresolved issues that support this concept. First, we will address the issue of the identity of cancer-initiating cells and the presence of cancer stem cells in growing tumors. We will also ask are there rare and distinct populations of cancer stem cells in established tumor cell lines, or are all of the cells cancer stem cells? Second, the most important clinical problem with cancer is its metastasis, and here a challenging question arises: by employing radio-chemotherapy for tumor treatment, do we unintentionally create a prometastatic microenvironment in collateral organs? Specifically, many factors upregulated in response to radio-chemotherapy-induced injury may attract highly migratory cancer cells that survived initial treatment. 1234567890();,: 1234567890();,: Third, what is the contribution of normal circulating stem cells to the growing malignancy? Do circulating normal stem cells recognize a tumor as a hypoxia-damaged tissue that needs
    [Show full text]
  • Cancer Stem Cells: a New Approach to Tumor Development
    REVIEW ARTICLE KOBAYASHI NCC ET AL. Cancer stem cells: a new approach to tumor development NATÁLIA CRISTINA CIUFA KOBAYASHI1*, SAMUEL MARCOS RIBEIRO DE NORONHA2 1Full Teaching Degree in Biological Sciences – Graduate degree in Molecular Biology, United Metropolitan Colleges (FMU), São Paulo, SP, Brazil 2PhD – Department of Allergy and Immunology, University of São Paulo (USP), São Paulo, SP, Brazil SUMMARY Many theories have been proposed to explain the origins of cancer. Currently, evidences show that not every tumor cell is capable of initiating a tumor. Only a small part of the cancer cells, called cancer stem cells (CSCs), can generate a tumor identical to the original one, when removed from human tumors and transplanted into immunosuppressed mice. The name given to these cells co- mes from the resemblance to normal stem cells, except for the fact that their abi- lity to divide is infinite. These cells are also affected by their microenvironment. Many of the signaling pathways, such as Wnt, Notch and Hedgehog, are altered in this tumoral subpopulation, which also contributes to abnormal prolifera- tion. Researchers have found several markers for CSCs; however, much remains to be studied, or perhaps a universal marker does not even exist, since they vary Study conducted at United among tumor types and even from patient to patient. It was also found that Metropolitan Colleges (FMU) cancer stem cells are resistant to radiotherapy and chemotherapy. This may ex- Article received: 4/24/2014 plain the re-emergence of the disease, since they are not completely eliminated Accepted for publication: 4/24/2014 and minimal amounts of CSCs can repopulate a tumor.
    [Show full text]
  • Advances in Therapeutic Targeting of Cancer Stem Cells Within the Tumor Microenvironment: an Updated Review
    cells Review Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review 1,2, , 1,2, 1,2, Kevin Dzobo * y , Dimakatso Alice Senthebane y, Chelene Ganz y, Nicholas Ekow Thomford 3,4 , Ambroise Wonkam 3 and Collet Dandara 3 1 International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town Component, Wernher and Beit Building (South), UCT Medical Campus, Anzio Road, Observatory, Cape Town 7925, South Africa; [email protected] (D.A.S.); [email protected] (C.G.) 2 Division of Medical Biochemistry and Institute of Infectious Disease and Molecular Medicine, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa 3 Division of Human Genetics, Department of Pathology and Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa; [email protected] (N.E.T.); [email protected] (A.W.); [email protected] (C.D.) 4 Department of Medical Biochemistry, School of Medical Sciences, College of Health Sciences, University of Cape Coast, PMB, Cape Coast, Ghana * Correspondence: [email protected]; Tel.: +27-842953708 These authors contributed equally to this work. y Received: 7 July 2020; Accepted: 11 August 2020; Published: 13 August 2020 Abstract: Despite great strides being achieved in improving cancer patients’ outcomes through better therapies and combinatorial treatment, several hurdles still remain due to therapy resistance, cancer recurrence and metastasis. Drug resistance culminating in relapse continues to be associated with fatal disease. The cancer stem cell theory posits that tumors are driven by specialized cancer cells called cancer stem cells (CSCs).
    [Show full text]
  • Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells
    Author Manuscript Published OnlineFirst on August 14, 2020; DOI: 10.1158/0008-5472.CAN-20-1079 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Article Cancer cell CD44 mediates macrophage/monocyte-driven regulation of head and neck cancer stem cells. Authors Karina E. Gomez1, FangLong Wu2,3, Stephen B. Keysar1, J. Jason Morton1, Bettina Miller1, Tugs-Saikhan Chimed1, Phuong N. Le1, Cera Nieto1, Farshad N. Chowdhury1, Anit Tyagi1, Traci R. Lyons1,4, Christian D. Young2, Hongmei Zhou3, Hilary L. Somerset2, Xiao-Jing Wang2,4,5, and Antonio Jimeno1,4. Affiliation 1 Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus (CU AMC), CO, 80045. 2 Department of Pathology, CU AMC, CO, 80045. 3 State Key Laboratory of Oral Diseases, Department of Oral Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu, China. 4 Gates Center for Regenerative Medicine, CU AMC, CO, 80045. 5 Veterans Affairs Medical Center, VA Eastern Colorado Health Care System, Aurora, CO, USA. Corresponding Author Antonio Jimeno M.D., Ph.D., Professor of Medicine/Oncology, and Otolaryngology. University of Colorado Cancer Center, and Gates Center for Regenerative Medicine. University of Colorado Anschutz Medical Campus. 12801 East 17th Avenue, Room L18-8101B, Aurora, CO 80045, USA. [email protected] 1 Downloaded from cancerres.aacrjournals.org on September 28, 2021. © 2020 American Association for Cancer Research. Author Manuscript Published OnlineFirst on August 14, 2020; DOI: 10.1158/0008-5472.CAN-20-1079 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
    [Show full text]
  • Identification of Cancer Stem Cell Subpopulations in Head and Neck
    cells Article Identification of Cancer Stem Cell Subpopulations in Head and Neck Metastatic Malignant Melanoma Vithushiya Yoganandarajah 1 , Josie Patel 1, Bede van Schaijik 1, Nicholas Bockett 1, Helen D. Brasch 1, Erin Paterson 1, Dalice Sim 2, Paul F. Davis 1, Imogen M. Roth 1 , Tinte Itinteang 1 and Swee T. Tan 1,3,4,* 1 Gillies McIndoe Research Institute, Newtown, Wellington 6021, New Zealand; [email protected] (V.Y.); [email protected] (J.P.); [email protected] (B.v.S.); [email protected] (N.B.); [email protected] (H.D.B.); [email protected] (E.P.); [email protected] (P.F.D.); [email protected] (I.M.R.); [email protected] (T.I.) 2 Biostatistical Group/Dean’s Department, University of Otago, Wellington 6242, New Zealand; [email protected] 3 Wellington Regional Plastic, Maxillofacial and Burns Unit, Hutt Hospital, Lower Hutt 5010, New Zealand 4 Department of Surgery, The University of Melbourne, Parkville, Victoria 3050, Australia * Correspondence: [email protected]; Tel.: +64-(0)-4-282-0366 Received: 13 November 2019; Accepted: 27 January 2020; Published: 30 January 2020 Abstract: Cancer stem cells (CSCs) have been identified in many cancer types. This study identified and characterized CSCs in head and neck metastatic malignant melanoma (HNmMM) to regional lymph nodes using induced pluripotent stem cell (iPSC) markers. Immunohistochemical (IHC) staining performed on 20 HNmMM tissue samples demonstrated expression of iPSC markers OCT4, SOX2, KLF4, and c-MYC in all samples, while NANOG was expressed at low levels in two samples.
    [Show full text]
  • Stem and Cancer Stem Cell Identities, Cellular Markers, Niche Environment and Response to Treatments to Unravel New Therapeutic Targets
    biology Editorial Stem and Cancer Stem Cell Identities, Cellular Markers, Niche Environment and Response to Treatments to Unravel New Therapeutic Targets Jose R. Pineda 1,2,* , Iker Badiola 1 and Gaskon Ibarretxe 1,* 1 Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain; [email protected] 2 Achucarro Basque Center for Neuroscience Fundazioa, 48940 Leioa, Spain * Correspondence: [email protected] (J.R.P.); [email protected] (G.I.); Tel.: +34-9460-12426 (J.R.P.); +34-9460-13218 (G.I.) Adult stem cells are a partially quiescent cell population responsible for natural cell renewal and are found in many different regions of the body, including the brain, teeth, bones, muscles, skin, and diverse epithelia, such as the epidermal or intestinal epithelium, among others. Interestingly, adult stem cell populations share all the instructions to grow and differentiate to any type of cell of the specific tissue they belong to. These normally quiescent stem cells can be activated on demand to replenish mature differentiated cell populations, a process which is driven mainly by signaling cues from its niche, thanks to the activation of their specific receptors in a timely and fine-tuned manner. One of the best examples of a very different niche regulation is the radically different turnover rate of intestinal stem cells with respect to neural stem cells. When someone evokes the word “cancer”, it can inspire fear and respect for a devas- Citation: Pineda, J.R.; Badiola, I.; tating and rampant disease, and similarly it could give the impression at first glance that it Ibarretxe, G.
    [Show full text]
  • C-Met As a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas
    cells Review C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas Paulina Marona 1 , Judyta Górka 1 , Jerzy Kotlinowski 1 , Marcin Majka 2 , Jolanta Jura 1 and Katarzyna Miekus 1,* 1 Department of General Biochemistry, Faculty of Biochemistry, Biopphisics and Biotechnology, Jagiellonian University, Gronostajowa Street 7, 30-387 Krakow, Poland; [email protected] (P.M.); [email protected] (J.G.); [email protected] (J.K.); [email protected] (J.J.) 2 Department of Transplantation, Jagiellonian University Medical College, Jagiellonian University, Wielicka 265, 30-663 Krakow, Poland; [email protected] * Correspondence: [email protected] Received: 28 February 2019; Accepted: 19 March 2019; Published: 22 March 2019 Abstract: C-Met tyrosine kinase receptor plays an important role under normal and pathological conditions. In tumor cells’ overexpression or incorrect activation of c-Met, this leads to stimulation of proliferation, survival and increase of motile activity. This receptor is also described as a marker of cancer initiating cells. The latest research shows that the c-Met receptor has an influence on the development of resistance to targeted cancer treatment. High c-Met expression and activation in renal cell carcinomas is associated with the progression of the disease and poor survival of patients. C-Met receptor has become a therapeutic target in kidney cancer. However, the therapies used so far using c-Met tyrosine kinase inhibitors demonstrate resistance to treatment. On the other hand, the c-Met pathway may act as an alternative target pathway in tumors that are resistant to other therapies.
    [Show full text]
  • Stem Cells and Cancer Awol Mekonnen Ali* College of Medicine, Institute of Medicine and Health Science, Debre Birhan University, Ethiopia
    ll Scienc Ce e f & o T l h a e n r a r a Ali, J Cell Sci Ther 2016, 7:5 p p u u y y o o J J Journal of Cell Science & Therapy DOI: 10.4172/2157-7013.1000255 ISSN: 2157-7013 Review Article Open Access Stem Cells and Cancer Awol Mekonnen Ali* College of Medicine, Institute of Medicine and Health science, Debre Birhan University, Ethiopia Abstract Stem cells are undifferentiated cells that can differentiate into specialized cell and can divide to produce more stem cells. The concept of cancer stem cells has been discussed in the scientific literature since the 19th century. Circumstantial evidence suggests that most tumors are heterogeneous and contain a small population of cancer stem cells that exhibit distinctive self-renewal, proliferation and differentiation capabilities, which are believed to play a crucial role in tumor progression, drug resistance, recurrence and metastasis in multiple malignancies. Unlike normal adult stem cells that remain constant in number, cancer stem cells can increase in number as tumors grow, and give rise to progeny that can be both locally invasive and colonize distant sites-the two hallmarks of malignancy. Rapid advances in the cancer stem cell field have provided cause for optimism for the development of more reliable cancer therapies in the future. Strategies aimed at efficient targeting of cancer stem cells are becoming important for monitoring the progress of cancer therapy and for evaluating new therapeutic approaches. Keywords: Cancer stem cell; Stem cell markers; Niche cells give rise to red blood cells, white blood cells and platelets, whereas skin stem cells give rise to the various types of skin cells.
    [Show full text]
  • CD44 Splice Isoform Switching Determines Breast Cancer Stem Cell State
    Downloaded from genesdev.cshlp.org on September 29, 2021 - Published by Cold Spring Harbor Laboratory Press CD44 splice isoform switching determines breast cancer stem cell state Honghong Zhang,1,2,5 Rhonda L. Brown,2,5 Yong Wei,3 Pu Zhao,1 Sali Liu,1,2 Xuan Liu,1 Yu Deng,1 Xiaohui Hu,1 Jing Zhang,1 Xin D. Gao,2 Yibin Kang,3 Arthur M. Mercurio,4 Hira Lal Goel,4 and Chonghui Cheng1,2 1Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA; 2Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA; 3Department of Molecular Biology, Princeton University, Princeton, New Jersey 08544, USA; 4Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, Massachusetts 01605, USA Although changes in alternative splicing have been observed in cancer, their functional contributions still remain largely unclear. Here we report that splice isoforms of the cancer stem cell (CSC) marker CD44 exhibit strikingly opposite functions in breast cancer. Bioinformatic annotation in patient breast cancer in The Cancer Genome Atlas (TCGA) database reveals that the CD44 standard splice isoform (CD44s) positively associates with the CSC gene signatures, whereas the CD44 variant splice isoforms (CD44v) exhibit an inverse association. We show that CD44s is the predominant isoform expressed in breast CSCs. Elimination of the CD44s isoform impairs CSC traits. Conversely, manipulating the splicing regulator ESRP1 to shift alternative splicing from CD44v to CD44s leads to an induction of CSC properties.
    [Show full text]
  • Activation of the HGF/C-Met Axis in the Tumor Microenvironment: a Multispecies Model
    Journal of Theoretical Biology 439 (2018) 86–99 Contents lists available at ScienceDirect Journal of Theoretical Biology journal homepage: www.elsevier.com/locate/jtbi Activation of the HGF/c-Met axis in the tumor microenvironment: A multispecies model ∗ Anna Konstorum a, , John S. Lowengrub b,c,d,e a Center for Quantitative Medicine, UConn Health, Farmington, CT, USA b Department of Mathematics, University of California, Irvine, CA, USA c Center for Complex Biological Systems, University of California, Irvine, CA, USA d Department of Biomedical Engineering, University of California, Irvine, CA, USA e Chao Family Comprehensive Cancer Center, University of California, Irvine, USA a r t i c l e i n f o a b s t r a c t Article history: The tumor microenvironment is an integral component in promoting tumor development. Cancer- Received 30 June 2017 associated fibroblasts (CAFs), which reside in the tumor stroma, produce Hepatocyte Growth Factor (HGF), Revised 24 October 2017 an important trigger for invasive and metastatic tumor behavior. HGF contributes to a pro-tumorigenic Accepted 30 November 2017 environment by activating its cognate receptor, c-Met, on tumor cells. Tumor cells, in turn, secrete growth Available online 5 December 2017 factors that upregulate HGF production in CAFs, thereby establishing a dynamic tumor-host signaling pro- Keywords: gram. Using a spatiotemporal multispecies model of tumor growth, we investigate how the development Cancer and spread of a tumor is impacted by the initiation of a dynamic interaction between tumor-derived Stem cell growth factors and CAF-derived HGF. We show that establishment of such an interaction results in in- Microenvironment creased tumor growth and morphological instability, the latter due in part to increased cell species het- Multiscale erogeneity at the tumor-host boundary.
    [Show full text]